These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4171642)

  • 21. Impotence therapy and cancer of the prostate.
    Guinan PD; Sadoughi W; Alsheik H; Ablin RJ; Alrenga D; Bush IM
    Am J Surg; 1976 May; 131(5):599-600. PubMed ID: 58562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled clinical trial of aldactone-A in the treatment of benign prostatic hyperplasia.
    Castro JE; Griffiths HJ; Edwards DE; Shackman R
    Br J Surg; 1969 Aug; 56(8):632. PubMed ID: 4185036
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug treatment for LUTS and BPH: new is not always better.
    Roehrborn CG
    Eur Urol; 2006 Jan; 49(1):5-7. PubMed ID: 16314029
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hormone treatment of benign prostatic hypertrophy].
    Sember M; Bernstein-Hahn L
    Rev Argent Urol Nefrol; 1969 Sep; 38(9):160-1. PubMed ID: 4190461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conservative treatment of prostatic adenoma].
    Gikov D; Bozhilov I
    Khirurgiia (Sofiia); 1974; 27(5):398-403. PubMed ID: 4143140
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical application of "PPC" to prostatic hypertrophy and others].
    Sugiura H; Shimaya M
    Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
    Urologiia; 2005; (5):25-6. PubMed ID: 16281835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 29. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study].
    Dörner G; Fritsche C
    ZFA (Stuttgart); 1982 Jan; 58(3):167-9. PubMed ID: 6176081
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kampo preparations for prostatic hyperplasia: usefulness of Saireito for nocturia].
    Sugiyama T; Oonishi N; Onoe M; Kurita T
    Hinyokika Kiyo; 2002 Jun; 48(6):343-6. PubMed ID: 12166233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of apha-blockaders in the treatment of prostatism].
    Penders L; Bouffioux C
    Acta Urol Belg; 1983; 51(4):518-31. PubMed ID: 6196958
    [No Abstract]   [Full Text] [Related]  

  • 34. [Splenectomy, androgens and corticosteroids in the therapy of myelofibrosis. Description of 2 clinical cases].
    Perugini S; Lusvarghi E; Sternieri E; Ferrari G
    Minerva Med; 1966 Sep; 57(70):2821-34. PubMed ID: 4288203
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormone therapy in inhibition of lactation].
    PORTELA PE
    Port Med; 1958 Mar; 42(3):175-82. PubMed ID: 13567151
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal management of the benign obstructing prostate: use of combined androgen-estrogen therapy.
    KAUFMAN JJ; GOODWIN WE
    Trans West Sect Am Urol Assoc; 1958; 25():40-6; discussion 47-8. PubMed ID: 13603564
    [No Abstract]   [Full Text] [Related]  

  • 39. [Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
    Lardennois B; El Khansa A; Amory JP; Coulon JM; Lemaire P
    J Urol (Paris); 1981; 87(4):243-8. PubMed ID: 6167646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of setegis administration after transvesical adenomectomy].
    Gorilovskiĭ LM; Zingerenko MB; Lakhno DA
    Urologiia; 2007; (6):61, 63-5. PubMed ID: 18649663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.